Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License. ​All of our articles are available to download individually in PDF format.


Considering Patients’ Needs: Action and Reaction of Interleukin-6 Blockade

Considering Patients’ Needs: Action and Reaction of Interleukin-6 Blockade

December 1, 2017 at 8:29 AM 0 comments

This symposium took place on 14th June 2017, as a part of the European League Against Rheumatism (EULAR) 18th Annual European Congress in Madrid, Spain Chairperson: Costantino Pitzalis1 Speakers: Josef S. Smolen,2 Ernest Choy3 1. Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and the London SchoolRead More

Interleukin-23: The Common Link Between the Joint, the Gut, and the Skin?

Interleukin-23: The Common Link Between the Joint, the Gut, and the Skin?

December 1, 2017 at 8:28 AM 0 comments

This symposium took place on 16th June 2017, as a part of the European League Against Rheumatism (EULAR) 18th Annual Congress in Madrid, Spain Chairpersons: Dennis McGonagle,1 Frank Behrens2 Speakers: Dennis McGonagle,1 Frank Behrens,2 Silvio Danese3 1. University of Leeds, Leeds, UK 2. Goethe University, Frankfurt, Germany 3. Humanitas University,Read More

The Treatment Approach of Idiopathic Inflammatory Myopathies

The Treatment Approach of Idiopathic Inflammatory Myopathies

November 30, 2017 at 8:28 AM 0 comments

Matthew J.S. Parker,1,2 Hector Chinoy1,2 1. NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK 2. Department of Rheumatology, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Salford, UK *Correspondence to hector.chinoy@manchester.ac.uk Disclosure: Matthew J.S. Parker is supported by anRead More

Ankylosing Spondylitis: A Review

Ankylosing Spondylitis: A Review

November 30, 2017 at 8:13 AM 0 comments

Farrouq Mahmood,1 *Philip Helliwell2 1. Bradford Teaching Hospitals, Bradford, UK 2. Leeds and Bradford Teaching Hospitals, Bradford, UK *Correspondence to p.helliwell@Leeds.ac.uk Disclosure: The authors have declared no conflicts of interests. Received: 28.02.17 Accepted: 15.08.17 Citation: EMJ. 2017;2[4]:134-139. Abstract Ankylosing spondylitis is a chronic autoimmune inflammatory condition belonging to the spondyloarthropathyRead More

Time To Control Gout and Make It Crystal Clear

Time To Control Gout and Make It Crystal Clear

November 20, 2017 at 8:30 AM 0 comments

This symposium took place on 15th June 2017, as part of the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology 2017 in Madrid, Spain Chairpersons: Fernando Perez-Ruiz,1 Thomas Bardin,2 Alexander So3 Speakers: Till Uhlig,4 Thomas Bardin,2 Pascal Richette,2 Alexander So,3 Fernando Perez-Ruiz1 1. Basque Country University, Baracaldo, SpainRead More

Biosimilars and Switching: What is Your Perspective?

Biosimilars and Switching: What is Your Perspective?

August 1, 2017 at 8:29 AM 0 comments

This satellite symposium took place on 16th June 2017 as a part of the European League Against Rheumatism (EULAR) Congress in Madrid, Spain Chairperson: John Isaacs1 Speakers: John Isaacs,1 Guro Løvik Goll,2 João Gonçalves,3 Ailsa Bosworth4 1. Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK 2. Department ofRead More

Switching Patients from Originator to Biosimilar Medications in Rheumatoid Arthritis: Limiting the ‘Nocebo’ Effect

Switching Patients from Originator to Biosimilar Medications in Rheumatoid Arthritis: Limiting the ‘Nocebo’ Effect

August 1, 2017 at 8:28 AM 0 comments

This symposium took place on 16th June as part of the European League Against Rheumatism (EULAR) Congress 2017 in Madrid, Spain Moderator: Chris Edwards1 Faculty: Merete Lund Hetland,2 Lars Erik Kristensen,2,3 Maria Cuadrado4 1. University of Southampton, Southampton, UK 2. University of Copenhagen, Copenhagen, Denmark 3. Lund University, Lund, SwedenRead More

The Patient’s Perspective on Psoriatic Arthritis: What More Can Rheumatologists Do to Optimise Disease Management?

The Patient’s Perspective on Psoriatic Arthritis: What More Can Rheumatologists Do to Optimise Disease Management?

August 1, 2017 at 8:27 AM 0 comments

This symposium took place on 16th June 2017 as a part of the European League Against Rheumatism (EULAR) Congress in Madrid, Spain Speakers: Juan Gomez-Reino,1 Ana-Maria Orbai,2 Laure Gossec3 1. Hospital Clinico Universitario de Santiago, La Coruña, Spain 2. Johns Hopkins University School of Medicine, Baltimore, Maryland, USA 3. Sorbonne Universités, UPMCRead More

Editor’s Pick: Why Do Diseases Start One Sided? Clues from HLA-B27 Acute Anterior Uveitis

Editor’s Pick: Why Do Diseases Start One Sided? Clues from HLA-B27 Acute Anterior Uveitis

August 1, 2017 at 8:26 AM 0 comments

In this intriguing article, Margo S. Clarke explores the fascinating topic of disease left–right asymmetry, putting HLA-B27 acute anterior uveitis under the spotlight. She explores the immune system’s exquisite selective ability to react to molecular variance and prompts further discussion on how a deeper understanding of lateralisation could impact theRead More

Osmolytes as Mediators of the Muscle Tissue’s Responses to Inflammation: Emerging Regulators of Myositis with Therapeutic Potential

Osmolytes as Mediators of the Muscle Tissue’s Responses to Inflammation: Emerging Regulators of Myositis with Therapeutic Potential

August 1, 2017 at 8:25 AM 0 comments

*Boel De Paepe Neuromuscular Reference Center & Department of Neurology, Ghent University Hospital, Ghent, Belgium *Correspondence to boel.depaepe@ugent.be Disclosure: The author has declared no conflicts of interest. Acknowledgements: The author is the recipient of a research grant from the Association Belge contre les Maladies neuro-Musculaires (ABMM), Aide à la RechercheRead More